| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 634.45M | 601.10M | 570.90M | 500.20M | 432.70M |
| Gross Profit | 478.25M | 474.70M | 450.30M | 347.10M | 425.50M |
| EBITDA | 418.70M | 397.90M | 366.90M | 310.50M | 304.10M |
| Net Income | 298.68M | 282.60M | 256.90M | 233.90M | 244.70M |
Balance Sheet | |||||
| Total Assets | 685.33M | 639.60M | 658.00M | 662.70M | 542.90M |
| Cash, Cash Equivalents and Short-Term Investments | 18.20M | 15.30M | 18.70M | 16.60M | 51.30M |
| Total Debt | 206.01M | 3.50M | 34.60M | 68.70M | 9.50M |
| Total Liabilities | 278.21M | 70.20M | 105.70M | 135.40M | 70.40M |
| Stockholders Equity | 407.12M | 569.40M | 552.30M | 527.30M | 472.50M |
Cash Flow | |||||
| Free Cash Flow | 303.76M | 300.60M | 283.70M | 263.40M | 275.40M |
| Operating Cash Flow | 331.50M | 304.60M | 287.50M | 266.80M | 278.20M |
| Investing Cash Flow | -23.27M | 1.60M | 1.80M | -129.60M | -2.80M |
| Financing Cash Flow | -305.29M | -309.60M | -287.20M | -171.90M | -269.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $2.23B | 11.03 | 3.51% | 0.00% | -11.00% | -28.35% | |
72 Outperform | $5.05B | 13.38 | 60.53% | 2.40% | 9.11% | 13.37% | |
71 Outperform | $2.69B | 18.52 | 41.93% | ― | 5.93% | 310.70% | |
65 Neutral | $7.62B | 124.60 | 1.28% | ― | 16.83% | ― | |
65 Neutral | $7.62B | 124.60 | 1.28% | ― | 16.83% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |